Prostate carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
UBCEP-1 mediated ubiquitin chain elongation may promote prostate carcinoma development by increasing via the proteasome pathway the degradation of proteins which are involved in growth inhibition or apoptosis.
|
15647830 |
2005 |
Seminoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Ubiquitin C (protein degradation) was down-regulated, GAPDH (carbohydrate metabolism), beta-actin (cytoskeleton), 18S rRNA (ribosome) and PBGD (porphyrin metabolism) were up-regulated in seminoma.
|
15823405 |
2005 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Ubiquitin C-terminal hydrolase 37 (UCH37) plays a crucial role in numerous biological processes and is also involved in oncogenesis.
|
23220010 |
2013 |
Chronic liver disease
|
0.010 |
Biomarker
|
group |
BEFREE |
Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease.
|
26264933 |
2015 |
Parkinson Disease
|
0.050 |
Biomarker
|
disease |
BEFREE |
Ubiquitin C-terminal Hydrolase-1 (UCHL1) is a deubiquitinating enzyme, which plays a key role in Parkinson's disease (PD).
|
28300150 |
2017 |
Tumor Cell Invasion
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
RPS27a also enhances LMP1-mediated proliferation and invasion, suggesting that RPS27a interacts with LMP1 and stabilizes it by suppressing proteasome-mediated ubiquitination.
|
28735865 |
2017 |
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
Ubiquitin C-terminal hydrolase deubiquitinase BAP1 is an essential tumor suppressor involved in cell growth control, DNA damage response, and transcriptional regulation.
|
30639226 |
2019 |
Retinal Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
A ubiquitin C-terminal hydrolase gene on the proximal short arm of the X chromosome: implications for X-linked retinal disorders.
|
8845848 |
1996 |
Prostatic Neoplasms
|
0.010 |
AlteredExpression
|
group |
LHGDN |
A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer.
|
15647830 |
2005 |
Hepatitis C
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes.
|
28667290 |
2017 |
Cystic Fibrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Associated pathways indicate that immune system is likely involved and that Ubiquitin C is probably a central node, linking Cystic Fibrosis to liver and pancreatic disease.
|
28339466 |
2017 |
Pancreatic Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Associated pathways indicate that immune system is likely involved and that Ubiquitin C is probably a central node, linking Cystic Fibrosis to liver and pancreatic disease.
|
28339466 |
2017 |
Cognition Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Correlation of ubiquitin C terminal hydrolase and S100β with cognitive deficits in young adults with mild traumatic brain injury.
|
28681747 |
2019 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
Correlation of ubiquitin C terminal hydrolase and S100β with cognitive deficits in young adults with mild traumatic brain injury.
|
28681747 |
2019 |
Parkinson Disease
|
0.050 |
Biomarker
|
disease |
BEFREE |
Drosophila Ubiquitin C-Terminal Hydrolase Knockdown Model of Parkinson's Disease.
|
29535397 |
2018 |
Cachexia
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Gene expression of ubiquitin C and proteasome subunits C2, C3, and C9 was not changed in the uremic animals, suggesting that other pathways are involved in this model of nonacidotic uremic cachexia.
|
15931394 |
2005 |
Parkinson Disease
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Genetic studies have identified mutations in alpha-synuclein and ubiquitin C-terminal hydrolase as rare causes of autosomal dominant PD and mutations in parkin as a cause of autosomal recessive PD.
|
12067634 |
2002 |
Parkinson Disease
|
0.050 |
Biomarker
|
disease |
BEFREE |
Genetic studies have implicated the neuronal ubiquitin C-terminal hydrolase (UCH) protein UCH-L1 in Parkinson's disease (PD) pathogenesis.
|
22076440 |
2012 |
Tumor Cell Invasion
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
HCC cell migration and invasion together with the interaction between PRDX1 and ubiquitin C-terminal hydrolase 37 (UCH37) were studied in vitro.
|
29377617 |
2018 |
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
Here we describe the small molecule b-AP15 as a previously unidentified class of proteasome inhibitor that abrogates the deubiquitinating activity of the 19S regulatory particle. b-AP15 inhibited the activity of two 19S regulatory-particle-associated deubiquitinases, ubiquitin C-terminal hydrolase 5 (UCHL5) and ubiquitin-specific peptidase 14 (USP14), resulting in accumulation of polyubiquitin. b-AP15 induced tumor cell apoptosis that was insensitive to TP53 status and overexpression of the apoptosis inhibitor BCL2.
|
22057347 |
2011 |
Atrial Fibrillation
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we investigated the effect of ubiquitin C-terminal hydrolase 1 (UCHL1), an important DUB, on the development of AF induced by angiotensin II (Ang II).
|
31700166 |
2020 |
Diabetic Nephropathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Highlights RPS27A and RPLP0 may be important genes in the treatment of MSCs for DN.
|
29532746 |
2018 |
Sudden infant death syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
However, using a single unstable reference gene for normalization resulted in no significant differences in transcript abundance of RPS27A between SIDS and the controls.
|
26434654 |
2015 |
Malignant Head and Neck Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition to these two genes, Ubiquitin C (UBC) in head and neck cancer and Transferrin receptor (TFRC) and β-Glucuronidase (GUSB) in pancreatic cancer were identified to be stable as well.
|
28262749 |
2017 |
Head and Neck Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition to these two genes, Ubiquitin C (UBC) in head and neck cancer and Transferrin receptor (TFRC) and β-Glucuronidase (GUSB) in pancreatic cancer were identified to be stable as well.
|
28262749 |
2017 |